Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated October 20, 2020, titled "Dr. Reddy s announces the re-launch of over-the-counter Famotidine Tablets USP, 10 mg and 20 mg, store-brand equivalent of Pepcid AC�� in the U.S. Market".
Press Release Oct 20 2020
Filed with NSE · · 2 pages · English
Watch Dr. Reddy's Laboratories' latest callDr. Reddy's Laboratories (NSE:DRREDDY) Q2 2027 Earnings Call · Replay · Oct 23Read the transcript of Dr. Reddy's Laboratories (NSE:DRREDDY) Q2 2027 Earnings CallRelease
Dr. Reddy's Laboratories Ltd. on 6ix
Earlier from Dr. Reddy's Laboratories
- Press Release Oct 17 2020
- Press Release Oct 12 2020
- Press Release Oct 05 2020
- Press Release Oct 03 2020
- Press Release Oct 01 2020
Later from Dr. Reddy's Laboratories
- Press Release Oct 28 2020
- Press Release Oct 29 2020
- Press Release Nov 12 2020
- Press Release Nov 28 2020
- Press Release Dec 01 2020
Follow Dr. Reddy's Laboratories into a list and get an email when it puts out news.
Follow Dr. Reddy's Laboratories